Cohort demographic and clinico-laboratory characteristics
| Feature . | Value . |
|---|---|
| Number of patients | 777 |
| Number of males | 198 (25.5%) |
| Median age (range) | 91 (81-104) |
| Median hemoglobin concentration, g/dL (range) | 13.1 (6.7-16.8) |
| Median MCV, fL (range) | 92.2 (58.6-121.8) |
| Median albumin concentration, g/L (range) | 3.58 (1.87-4.78) |
| Median γ globulin concentration, g/dL (range) | 1.06 (0.35-2.98) |
| MGUS prevalence | 75/777 (9.7%) |
| CH prevalence | 127/732 (17.3%) |
| M-CHIP prevalence | 114/732 (15.5%) |
| Prevalence of concomitant MGUS and CH | 7/732 (1%) |
| Prevalence of concomitant MGUS and M-CHIP | 7/732 (1%) |
| Feature . | Value . |
|---|---|
| Number of patients | 777 |
| Number of males | 198 (25.5%) |
| Median age (range) | 91 (81-104) |
| Median hemoglobin concentration, g/dL (range) | 13.1 (6.7-16.8) |
| Median MCV, fL (range) | 92.2 (58.6-121.8) |
| Median albumin concentration, g/L (range) | 3.58 (1.87-4.78) |
| Median γ globulin concentration, g/dL (range) | 1.06 (0.35-2.98) |
| MGUS prevalence | 75/777 (9.7%) |
| CH prevalence | 127/732 (17.3%) |
| M-CHIP prevalence | 114/732 (15.5%) |
| Prevalence of concomitant MGUS and CH | 7/732 (1%) |
| Prevalence of concomitant MGUS and M-CHIP | 7/732 (1%) |
MGUS, monoclonal gammopathy of undetermined significance; CH, clonal hematopoiesis; M-CHIP, myeloid clonal hematopoiesis of indeterminate potential.